Laura Indolfi
About Laura Indolfi
Laura Indolfi is the Co-Founder & CEO of PanTher Therapeutics, an early stage spin-out from MIT and MGH that provides superior technologies for revolutionizing the treatment of locally advanced solid tumors. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledge to drive the company’s vision. Prior to PanTher, she was a research associate at the Harvard-MIT Institute for Medical Engineering and Science, and served as an entrepreneur-in-residence at the MGH Cancer Center. She strongly believes in the power of outreaching initiatives to promote research awareness and foster the public audiences discovery of the beauty of science. In 2014 the line of clothes Cytocouture, created in collaboration with Colombian designer Carlos Villamil and inspired by her cell-therapy research, won the global competition Descience. In 2016, she was named a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world. In 2017, she attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing executives, entrepreneurs and innovators in business. Laura is also one of the 5 women selected by Massachusetts Life Science Center and Takeda for their inaugural class in 2018 of MassNextGen program, honoring exceptional leaders in the biotech industry. SPECIALTIES: * Multiple therapeutic areas, * Inflammatory/cardiovascular/neoplastic diseases, * smart biomaterials, * biodegradable polymers, * local, controlled and sustained drug delivery, * cell therapies, * translational medicine, * start up, * entrepreneurship, * strategic planning.